Publications

Zhang, D; Tang, W; Niu, H; Tse, W; Ruan, HB; Dolznig, H; Knösel, T; Karl-Heinz, F; Themanns, M; Wang, J; et al. Monogenic deficiency in murine intestinal Cdc42 leads to mucosal inflammation that induces crypt dysplasia. Genes and Diseases. 2024; 11:413-429.

Roberts, CM; Plevinsky, JM; Gamwell, KL; Noser, AE; Denson, LA; Hommel, KA. Self-Management assistance for recommended treatment (SMART) IBD app randomized control trial in adolescents with IBD: Design and methodology. 2024; 2:100031.

Sosnovski, KE; Braun, T; Amir, A; BenShoshan, M; Abbas-Egbariya, H; Ben-Yishay, R; Anafi, L; Avivi, C; Barshack, I; Denson, LA; et al. Reduced LHFPL3-AS2 lncRNA expression is linked to altered epithelial polarity and proliferation, and to ileal ulceration in Crohn disease. Scientific Reports. 2023; 13:20513.

Venkateswaran, S; Somineni, HK; Matthews, JD; Kilaru, V; Hyams, JS; Denson, LA; Kellamayer, R; Gibson, G; Cutler, DJ; Conneely, KN; et al. Longitudinal DNA methylation profiling of the rectal mucosa identifies cell-specific signatures of disease status, severity and clinical outcomes in ulcerative colitis cell-specific DNA methylation signatures of UC. Clinical Epigenetics. 2023; 15:50.

Velez Lopez, A; Waddell, A; Antonacci, S; Castillo, D; Santucci, N; Ollberding, NJ; Eshleman, EM; Denson, LA; Alenghat, T. Microbiota-derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient-derived colonoids. Neurogastroenterology and Motility. 2023; 35:e14681.

Wu, Y; Gettler, K; Kars, ME; Giri, M; Li, D; Bayrak, CS; Zhang, P; Jain, A; Maffucci, P; Sabic, K; et al. Identifying high-impact variants and genes in exomes of Ashkenazi Jewish inflammatory bowel disease patients. Nature Communications. 2023; 14:2256.

Dike, C; Ollberding, N; Thompson, T; Kotha, N; Minar, P; Vitale, D; Lin, T; Nasr, A; Denson, L; Haslam, D; et al. Acute pancreatitis is associated with gut dysbiosis in children. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2023; 23:e3-e4.

Zulqarnain, F; Zhao, X; Setchell, K; Sharma, Y; Fernandes, P; Srivastava, A; Ehsan, L; Jain, V; Raghavan, SS; Moskaluk, C; et al. Integrative –‘Omics and Machine-Learning-Based Image Analyses of Environmental Enteric Dysfunction Reveal an Immunologic and Metabolic Pathogenesis of Intestinal Failure. 2023.

Wang, YM; Abdullah, S; Luebbering, N; Langenberg, L; Duell, A; Lake, K; Lane, A; Hils, B; Silva, OV; Trapp, M; et al. Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood Advances. 2023; 7:5137-5151.

Raygoza Garay, JA; Turpin, W; Lee, SH; Smith, MI; Goethel, A; Griffiths, AM; Moayyedi, P; Espin-Garcia, O; Abreu, M; Aumais, GL; et al. Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives. Gastroenterology. 2023; 165:670-681.

Smith, J; Liu, C; Beck, A; Fei, L; Brokamp, C; Meryum, S; Whaley, KG; Minar, P; Hellmann, J; Denson, LA; et al. Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. The Journal of Pediatrics. 2023; 260:113522.

Braun, T; Sosnovski, KE; Amir, A; BenShoshan, M; VanDussen, KL; Karns, R; Levhar, N; Abbas-Egbariya, H; Hadar, R; Efroni, G; et al. Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease. JCI insight. 2023; 8:e170181.

Castillo, DF; Denson, LA; Haslam, DB; Hommel, KA; Ollberding, NJ; Sahay, R; Santucci, NR. The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation. Neurogastroenterology and Motility. 2023; 35:e14573.

Khandelwal, P; Lounder, DT; Bartlett, A; Haberman, Y; Jegga, AG; Ghandikota, S; Koo, J; Luebbering, N; Leino, D; Abdullah, S; et al. Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica: the hematology journal. 2023; 108:1803-1816.

Sosnovski, KE; Braun, T; Amir, A; Moshel, D; Benshoshan, M; Vandussen, KL; Levhar, N; Abbas-Egbariya, H; Beider, K; Ben-Yishay, R; et al. GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis. 2023; 17:960-971.

Dike, C; Ollberding, N; Thompson, T; Kotha, N; Minar, PP; Vitale, DS; Lin, TK; Nasr, A; Denson, LA; Haslam, D; et al. Su1884 ACUTE PANCREATITIS IS ASSOCIATED WITH GUT DYSBIOSIS IN CHILDREN. Gastroenterology. 2023; 164:s-703.

Smith, J; Howard, CA; Etter, R; Hellmann, J; Whaley, KG; Minar, PP; Denson, LA; Margolis, P; Dhaliwal, J. Su1013 EVALUATION OF INSURANCE TYPE ON PRIOR AUTHORIZATION (PA) DELAYS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS PRESCRIBED BIOLOGIC THERAPIES. Gastroenterology. 2023; 164:s-504-s-505.

Liu, X; Reigle, J; Sharma, M; Lopez-Nunez, O; Walters, TD; Collins, MH; Hyams, JS; Siddiqui, I; Denson, LA; Jegga, A; et al. 783 DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. 2023; 164:s-170.

Jurickova, I; Dreskin, B; Angerman, E; Bonkowski, E; Denson, LA. 675 EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN'S DISEASE. Gastroenterology. 2023; 164:s-132-s-133.

Whaley, KG; Xiong, Y; Karns, R; Hyams, JS; Kugathasan, S; Boyle, BM; Walters, TD; Kelsen, J; LeLeiko, N; Shapiro, J; et al. Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023; 21:1338-1347.

Liu, Z; Liu, R; Gao, H; Jung, S; Gao, X; Sun, R; Liu, X; Kim, Y; Lee, HS; Kawai, Y; et al. Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nature Genetics. 2023; 55:796-806.

Dreskin, B; Jurickova, I; Angerman, E; Bonkowski, E; Denson, L. EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology. 2023; 164:s97-s98.

Dhaliwal, J; Liu, X; Reigle, J; Sharma, M; Lopez-Nunez, O; Walters, T; Collins, M; Hyams, J; Siddiqui, I; Denson, L; et al. DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology. 2023; 164:s72-s73.

Colman, RJ; Mizuno, T; Fukushima, K; Haslam, DB; Hyams, JS; Boyle, B; Noe, JD; D'Haens, GR; Van Limbergen, J; Chun, K; et al. Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology and Therapeutics. 2023; 57:524-539.

Hellmann, J; Ta, A; Ollberding, NJ; Bezold, R; Lake, K; Jackson, K; Dirksing, K; Bonkowski, E; Haslam, DB; Denson, LA. Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2023; 29:286-296.

Shih, T; Yusung, S; Gonsky, R; Dutra-Clarke, R; Ziring, D; Rabizadeh, S; Kugathasan, S; Denson, LA; Li, D; Braun, J. Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory Bowel Diseases. 2023; 29:328-331.

Dhaliwal, J; Liu, X; Reigle, J; Sharma, M; Lopez-Nunez, O; Walters, T; Collins, M; Hyams, J; Siddiqui, I; Denson, L; et al. DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 2023; 29:s56-s57.

Dreskin, B; Jurickova, I; Angerman, E; Bonkowski, E; Denson, L. EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases. 2023; 29:s76-s77.

Shah, R; Hoffman, K; Denson, L; Kugathasan, S; Kellermayer, R. Mucosal microbiome is predictive of pediatric Crohn's disease across geographic regions in North America. F1000Research. 2023; 11:156.

Abu-Ata, N; Dillman, JR; Rubin, JM; Collins, MH; Johnson, LA; Imbus, RS; Bonkowski, EL; Denson, LA; Higgins, PD R. Ultrasound shear wave elastography in pediatric stricturing small bowel Crohn disease: correlation with histology and second harmonic imaging microscopy. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2023; 53:34-45.

Hommel, KA; Ramsey, RR; Gray, WN; Denson, LA. Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 2023; 76:38-42.

Dillman, JR; Ata, NA; Towbin, AJ; Anton, CG; Smith, EA; Zhang, B; Imbus, R; Tkach, JA; Denson, LA. The Simplified MR Index of Activity Score in Pediatric Small-Bowel Crohn Disease: An Interreader Agreement and Responsiveness Study. American Journal of Roentgenology. 2023; 220:126-133.

Abbas-Egbariya, H; Haberman, Y; Braun, T; Hadar, R; Denson, L; Gal-Mor, O; Amir, A. Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biology: biology for the post-genomic era. 2022; 23:61.

Clarkston, K; Karns, R; Jegga, AG; Sharma, M; Fox, S; Ojo, BA; Minar, P; Walters, TD; Griffiths, AM; Mack, DR; et al. Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. Journal of Crohn's and Colitis. 2022; 16:1735-1750.

Lin, SN; Musso, A; Wang, J; Mukherjee, PK; West, GA; Mao, R; Lyu, R; Li, J; Zhao, S; Elias, M; et al. Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation. Matrix Biology. 2022; 113:1-21.

Bein, A; Fadel, CW; Swenor, B; Cao, W; Powers, RK; Camacho, DM; Naziripour, A; Parsons, A; LoGrande, N; Sharma, S; et al. Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction. Nature Biomedical Engineering. 2022; 6:1236-1247.

Dillman, JR; Tkach, JA; Imbus, R; Towbin, AJ; Denson, LA. MRI-Based Characterization of Intestinal Motility in Children and Young Adults With Newly Diagnosed Ileal Crohn Disease Treated by Biologic Therapy: A Controlled Prospective Study. American Journal of Roentgenology. 2022; 219:655-664.

Mahalingam, N; Tkach, JA; Denson, LA; Dillman, JR. Bowel wall MRI T1 relaxation estimates for assessment of intestinal inflammation in pediatric Crohn's disease. Abdominal Radiology. 2022; 47:2730-2738.

Jurickova, I; Bonkowski, E; Angerman, E; Novak, E; Huron, A; Akers, G; Iwasawa, K; Braun, T; Hadar, R; Hooker, M; et al. Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures. Inflammatory Bowel Diseases. 2022; 28:988-1003.

Ata, NA; Dillman, JR; Gandhi, D; Dudley, JA; Trout, AT; Imbus, R; Towbin, AJ; Denson, LA; Tkach, JA. Velocity-Encoded Phase-Contrast MRI for Measuring Mesenteric Blood Flow in Patients With Newly Diagnosed Small-Bowel Crohn Disease. American Journal of Roentgenology. 2022; 219:132-141.

Lipstein, EA; Brinkman, WB; Zhang, Y; Hommel, KA; Ittenbach, RF; Liu, C; Denson, LA. Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention. Patient Education and Counseling. 2022; 105:1075-1081.

Scheel, R; Geem, D; Venkateswaran, S; Pelia, RS; Alazraki, A; Dillman, J; Hyams, JS; Denson, LA; Kugathasan, S. Sa1590: RADIOGRAPHIC PROGRESSION AND THE EFFECT OF ANTI-TUMOR NECROSIS FACTOR IN CHILDREN WITH TREATMENT NAÏVE CROHN'S DISEASE. Gastroenterology. 2022; 162:s-428-s-429.

Shoda, T; Collins, MH; Rochman, M; Wen, T; Caldwell, JM; Mack, LE; Osswald, GA; Besse, JA; Haberman, Y; Aceves, SS; et al. Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162:1635-1649.

Venkateswaran, S; Somineni, HK; Kilaru, V; Katrinli, S; Prince, J; Okou, DT; Hyams, JS; Denson, LA; Kellermayer, R; Gibson, G; et al. Methylation quantitative trait loci are largely consistent across disease states in Crohn's disease. Editor, Myers C. G3-Genes Genomes Genetics. 2022; 12:jkac041.

Colman, RJ; Xiong, Y; Mizuno, T; Hyams, JS; Noe, JD; Boyle, B; D’Haens, GR; van Limbergen, J; Chun, K; Yang, J; et al. Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 2022; 55:593-603.

Hyams, JS; Brimacombe, M; Haberman, Y; Walters, T; Gibson, G; Mo, A; Mack, D; Griffiths, A; Boyle, B; Leleiko, N; et al. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflammatory Bowel Diseases. 2022; 28:151-160.

Colman, R; Mizuno, T; Hyams, J; Noe, J; Boyle, B; Denson, L; Vinks, A; Minar, P. REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Gastroenterology. 2022; 162:s100.

Jurickova, I; Huron, A; Angerman, E; Bonkowski, E; Jegga, A; Haberman, Y; Denson, L. EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology. 2022; 162:s62-s63.

Haberman, Y; Vallance, J; Baverman, J; Liu, T; Kugathasan, S; Denson, L; VanDussen, K. ILEAL ENTEROCYTE BRUSH BORDER ABNORMALITIES ASSOCIATE WITH PROGRESSIVE DISEASE COURSE IN PEDIATRICS CROHN’S DISEASE. Gastroenterology. 2022; 162:s49-s50.

Colman, R; Mizuno, T; Hyams, J; Noe, J; Boyle, B; Denson, L; Vinks, A; Minar, P. REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Inflammatory Bowel Diseases. 2022; 28:s100.

Jurickova, I; Huron, A; Angerman, E; Bonkowski, E; Jegga, A; Haberman, Y; Denson, L. EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases. 2022; 28:s62-s63.

Krishnakumar, C; Ananthakrishnan, AN; Boyle, BM; Griffiths, AM; LeLeiko, NS; Mack, DR; Markowitz, JF; Rosh, JR; Sauer, CG; Walters, TD; et al. Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 2022; 74:72-78.

Zhao, X; Setchell, KD R; Huang, R; Mallawaarachchi, I; Ehsan, L; Dobrzykowski, E; Zhao, J; Syed, S; Ma, JZ; Iqbal, NT; et al. Bile Acid Profiling Reveals Distinct Signatures in Undernourished Children with Environmental Enteric Dysfunction. The Journal of nutrition. 2021; 151:3689-3700.

Soomro, S; Venkateswaran, S; Vanarsa, K; Kharboutli, M; Nidhi, M; Susarla, R; Zhang, T; Sasidharan, P; Lee, KH; Rosh, J; et al. Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen. Nature Communications. 2021; 12:3989.

Moorman, EL; Farrell, M; Santucci, N; Denson, L; Le, C; Cunningham, NR. Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders. BMC Research Notes. 2021; 14:360.

Pelia, R; Venkateswaran, S; Matthews, JD; Haberman, Y; Cutler, DJ; Hyams, JS; Denson, LA; Kugathasan, S. Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease. BMC Medical Genomics. 2021; 14:194.

Ta, AD; Ollberding, NJ; Karns, R; Haberman, Y; Alazraki, AL; Hercules, D; Baldassano, R; Markowitz, J; Heyman, MB; Kim, S; et al. Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease. Inflammatory Bowel Diseases. 2021; 27:1707-1718.

Mo, A; Nagpal, S; Gettler, K; Haritunians, T; Giri, M; Haberman, Y; Karns, R; Prince, J; Arafat, D; Hsu, NY; et al. Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression. The American Journal of Human Genetics. 2021; 108:1765-1779.

Denson, LA. Application of mucosal functional genomics to childhood undernutrition and stunting: Insights into mechanisms and targeted interventions. EBioMedicine. 2021; 71:103553.

Colman, RJ; Tsai, YT; Jackson, K; Boyle, BM; Noe, JD; Hyams, JS; D'Haens, GR A M; Van Limbergen, J; Rosen, MJ; Denson, LA; et al. Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease. Inflammatory Bowel Diseases. 2021; 27:1045-1051.

Xiong, Y; Mizuno, T; Colman, R; Hyams, J; Noe, JD; Boyle, B; Tsai, YT; Dong, M; Jackson, K; Punt, N; et al. Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease. Clinical Pharmacology and Therapeutics. 2021; 109:1639-1647.

Aschenbrenner, D; Quaranta, M; Banerjee, S; Ilott, N; Jansen, J; Steere, B; Chen, YH; Ho, S; Cox, K; Arancibia-Cárcamo, CV; et al. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 2021; 70:1023-1036.

Verburgt, C; Dunn, K; Bielawski, J; Otley, A; Heyman, M; Sunseri, W; Shouval, D; Levine, A; de Meij, T; Hyams, J; et al. OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients. Journal of Crohn's and Colitis. 2021; 15:s030.

Hellmann, J; Etter, RK; Denson, LA; Minar, P; Hill, D; Dykes, DM; Rosen, MJ. Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease. Pediatric Quality and Safety. 2021; 6:e400.

Grasberger, H; Magis, AT; Sheng, E; Conomos, MP; Zhang, M; Garzotto, LS; Hou, G; Bishu, S; Nagao-Kitamoto, H; El-Zaatari, M; et al. DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk. The Journal of Clinical Investigation. 2021; 131:141676.

Haberman, Y; Iqbal, NT; Ghandikota, S; Mallawaarachchi, I; Tzipi Braun, ; Dexheimer, PJ; Rahman, N; Hadar, R; Sadiq, K; Ahmad, Z; et al. Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction. Gastroenterology. 2021; 160:2055-2071.e0.

Haberman, Y; Iqbal, NT; Ghandikota, S; Mallawaarachchi, I; Braun, T; Dexheimer, PJ; Rehman, NU; Hadar, R; Sadiq, K; Ahmad, Z; et al. Su094 IMMUNE AND METABOLIC PATHOGENESIS OF ENVIRONMENTAL ENTERIC DYSFUNCTION IN CHILDHOOD UNDERNUTRITION: A BIRTH INCEPTION COHORT. Gastroenterology. 2021; 160:s-615.

Minar, PP; Jegga, A; Ghandikota, S; Karns, R; Hyams, JS; Noe, JD; Boyle, BM; Rosen, MJ; Denson, LA. 728 PLASMA PROTEOMIC RESPONSE SIGNATURE FOR CHILDREN RECEIVING INFLIXIMAB FOR CROHN'S DISEASE. Gastroenterology. 2021; 160:s-145-s-146.

Whaley, KG; Xiong, Y; Karns, R; Hyams, JS; Kugathasan, S; Boyle, BM; Walters, TD; Kelsen, JR; Leleiko, NS; Shapiro, JM; et al. 727 ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology. 2021; 160:s-145.

Lyles, JL; Mulgund, AA; Bauman, LE; Su, W; Fei, L; Chona, DL; Sharma, P; Etter, RK; Hellmann, J; Denson, LA; et al. Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2021; 27:482-492.

Short, SP; Pilat, JM; Barrett, CW; Reddy, VK; Haberman, Y; Hendren, JR; Marsh, BJ; Keating, CE; Motley, AK; Hill, KE; et al. Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. Gastroenterology. 2021; 160:1694-1708.e3.

Somineni, HK; Nagpal, S; Venkateswaran, S; Cutler, DJ; Okou, DT; Haritunians, T; Simpson, CL; Begum, F; Datta, LW; Quiros, AJ; et al. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. The American Journal of Human Genetics. 2021; 108:431-445.

Whaley, K; Xiong, V; Karns, R; Hyams, J; Kugathasan, S; Boyle, B; Walters, T; Kelsen, J; LeLeiko, N; Shapiro, J; et al. ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology. 2021; 160:s75-s76.

Potdar, AA; Dube, S; Naito, T; Li, K; Botwin, G; Haritunians, T; Li, D; Casero, D; Yang, S; Bilsborough, J; et al. Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease. Gastroenterology. 2021; 160:809-822.e7.

Haberman, Y; Minar, P; Karns, R; Dexheimer, PJ; Ghandikota, S; Tegge, S; Shapiro, D; Shuler, B; Venkateswaran, S; Braun, T; et al. Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease. Journal of Crohn's and Colitis. 2021; 15:273-286.

Whaley, K; Xiong, V; Karns, R; Hyams, J; Kugathasan, S; Boyle, B; Walters, T; Kelsen, J; LeLeiko, N; Shapiro, J; et al. ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Inflammatory Bowel Diseases. 2021; 27:s55-s56.

Gray, WN; Wagoner, ST; Schaefer, MR; Reed, B; Morgan, P; Holbrook, E; Yacyshyn, B; MacKner, L; Young, M; Maddux, M; et al. Transition to Adult IBD Care: A Pilot Multi-Site, Telehealth Hybrid Intervention. Journal of Pediatric Psychology. 2021; 46:1-11.

Niklinska-Schirtz, BJ; Venkateswaran, S; Anbazhagan, M; Kolachala, VL; Prince, J; Dodd, A; Chinnadurai, R; Gibson, G; Denson, LA; Cutler, DJ; et al. Ileal Derived Organoids From Crohn's Disease Patients Show Unique Transcriptomic and Secretomic Signatures. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1267-1280.

Ungaro, RC; Hu, L; Ji, J; Nayar, S; Kugathasan, S; Denson, LA; Hyams, J; Dubinsky, MC; Sands, BE; Cho, JH. Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 2021; 53:281-290.

Uddin, J; Tomar, S; Sharma, A; Waggoner, L; Ganesan, V; Marella, S; Yang, Y; Noah, T; Vanoni, S; Patterson, A; et al. PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1479-1502.

Sali, R; Adewole, S; Ehsan, L; Denson, LA; Kelly, P; Amadi, BC; Holtz, L; Ali, SA; Moore, SR; Syed, S; et al. Hierarchical Deep Convolutional Neural Networks for Multi-category Diagnosis of Gastrointestinal Disorders on Histopathological Images. 2020 IEEE International Conference on Healthcare Informatics (ICHI). 2020; 00:1-6.

Lam, S; Singh, R; Dillman, JR; Trout, AT; Serai, SD; Sharma, D; Sheridan, R; Su, W; Fei, L; Karns, R; et al. Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease. Hepatology Communications. 2020; 4:1680-1693.

Wu, S; Hashimoto-Hill, S; Woo, V; Eshleman, EM; Whitt, J; Engleman, L; Karns, R; Denson, LA; Haslam, DB; Alenghat, T. Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature. 2020; 586:108-112.

Abu-El-Haija, M; Hornung, L; Lin, TK; Nathan, JD; Thompson, T; Vitale, DS; Nasr, A; Husain, SZ; Denson, L. Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2020; 20:1103-1108.

Mack, DR; Saul, B; Boyle, B; Griffiths, A; Sauer, C; Markowitz, J; LeLeiko, N; Keljo, D; Rosh, JR; Baker, SS; et al. Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:354-360.

Plevinsky, JM; Denson, LA; Hellmann, J; Minar, P; Rosen, MJ; Hommel, KA. A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:366-370.

Hellmann, J; Andersen, H; Fei, L; Linn, A; Bezold, R; Lake, K; Jackson, K; Meyer, D; Dirksing, K; Bonkowski, E; et al. Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Inflammatory Bowel Diseases. 2020; 26:1212-1221.

TA, A; Ollberding, N; Karns, R; Haberman, Y; Baldassano, RN; Markowitz, J; Heyman, M; Kirschner, BS; Oliva-Hemker, M; Pfefferkorn, MD; et al. 1162 BASELINE ILEAL LUMINAL NARROWING IS ASSOCIATED WITH SPECIFIC PRE-TREATMENT MUCOSAL GENE PROGRAMS AND MICROBIAL SHIFTS AND SUBSEQUENT LIKELIHOOD OF TRANSMURAL HEALING IN PEDIATRIC CROHN'S DISEASE. Gastroenterology. 2020; 158:s-234-s-235.

Minar, PP; Xiong, Y; Mizuno, T; Colman, RJ; Hyams, JS; Noe, JD; Boyle, BM; Chun, KY; Yang, JM; Tsai, YT; et al. 1160 REAL-WORLD PEDIATRIC INFLIXIMAB PHARMACOKINETIC MODEL VERIFIES CRITICAL NEED FOR PRECISION DOSING SOFTWARE. Gastroenterology. 2020; 158:s-233-s-234.

Colman, RJ; Xiong, Y; Mizuno, T; Hyams, JS; Noe, JD; Boyle, BM; Chun, KY; Yang, JM; Rosen, MJ; Denson, LA; et al. 613 ANTIBODIES TO INFLIXIMAB ACCELERATE DRUG CLEARANCE WHILE INTENSIFICATION STRATEGIES REVERSE IMMUNOGENICITY AND RECAPTURE CLINICAL RESPONSE. Gastroenterology. 2020; 158:s-130-s-131.

Haberman, Y; Minar, PP; Karns, R; Dexheimer, PJ; Ghandikota, S; Tegge, S; Shapiro, D; Shuler, B; Venkateswaran, S; Braun, T; et al. 935 PRE-TREATMENT MUCOSAL INFLAMMATORY AND WOUND HEALING GENE PROGRAMS REVEAL MECHANISMS ASSOCIATED WITH FUTURE STRICTURING BEHAVIOR DURING FIVE YEAR FOLLOW-UP IN PEDIATRIC CROHN'S DISEASE. Gastroenterology. 2020; 158:s-187-s-188.

Potdar, AA; Dube, S; Naito, T; Botwin, G; Haritunians, T; Li, D; Yang, S; Bilsborough, J; Denson, LA; Daly, M; et al. Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease. 2020; 1:2020.04.19.20070995.

Shapiro, JM; El-Serag, HB; Gandle, C; Peacock, C; Denson, LA; Fishman, LN; Hernaez, R; Hou, JK. Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clinical Gastroenterology and Hepatology. 2020; 18:276-289.e2.

Haberman Ziv, Y; Loberman-Nachum, N; Katya, S; Di Segni, A; Efroni, G; Braun, T; BenShoshan, M; Shouval, D; Denson, LA; Amir, A; et al. OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis. Journal of Crohn's and Colitis. 2020; 14:s006.

Haberman Ziv, Y; Minar, P; Karns, R; Dexheimer, P; Ghandikota, S; Tegge, S; Shapiro, D; Shuler, B; Venkateswaran, S; Braun, T; et al. DOP89 Pre-treatment mucosal inflammatory and wound healing gene programmes reveal mechanisms associated with future stricturing behaviour during 5-year follow-up in paediatric Crohn’s disease. Journal of Crohn's and Colitis. 2020; 14:s127.

Denson, LA. Mitochondrial Networks: A New Therapeutic Target in Colitis. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2020; 10:426-427.

Contact Us

A photo of Lee A. Denson.

Lee Denson, MD
Associate Professor
UC Department of Pediatrics


Mailing Address:
Division of Gastroenterology, Hepatology and Nutrition
3333 Burnet Ave.
MLC 2010
Cincinnati, OH 45229-3039

Phone: 513-636-7575
Fax: 513-636-5581
Email: lee.denson@cchmc.org